Publications by authors named "C Siewert"

Background: Intracerebral schwannomas are rare tumors resembling their peripheral nerve sheath counterparts but localized in the CNS. They are not classified as a separate tumor type in the 2021 WHO classification. This study aimed to compile and characterize these rare neoplasms morphologically and molecularly.

View Article and Find Full Text PDF

Endotoxin, a synonym for lipopolysaccharide (LPS), is anchored in the outer membranes of Gram-negative bacteria. Even minute amounts of LPS entering the circulatory system can have a lethal immunoactivating effect. Since LPS is omnipresent in the environment, it poses a great risk of contaminating any surface or solution, including research products and pharmaceuticals.

View Article and Find Full Text PDF
Article Synopsis
  • Endotoxins (lipopolysaccharides) from Gram-negative bacteria can trigger severe immune responses, necessitating strict limits on their presence in injectable drugs, leading to the need for effective removal systems.
  • Most current endotoxin removal methods are non-specific, which can accidentally remove important proteins from drug formulations, causing issues in efficacy.
  • This study introduces anti-Lipid A antibody-conjugated microparticles that selectively target and remove endotoxins without losing essential proteins, demonstrating higher recovery rates in various formulations compared to traditional non-specific methods.
View Article and Find Full Text PDF

Background: DNA methylation-based tumor classification allows an enhanced distinction into subgroups of glioblastoma. However, the clinical benefit of DNA methylation-based stratification of glioblastomas remains inconclusive.

Methods: Multicentric cohort study including 430 patients with newly diagnosed glioblastoma subjected to global DNA methylation profiling.

View Article and Find Full Text PDF

Hematopoietic stem cell transplantation (HSCT) from haploidentical donors is a viable option for patients lacking HLA-matched donors. Here we report the results of a prospective multicenter phase I/II trial of transplantation of TCRαβ and CD19-depleted peripheral blood stem cells from haploidentical family donors after a reduced-intensity conditioning with fludarabine, thiotepa, and melphalan. Thirty pediatric and 30 adult patients with acute leukemia (n = 43), myelodysplastic or myeloproliferative syndrome (n = 6), multiple myeloma (n = 1), solid tumors (n = 6), and non-malignant disorders (n = 4) were enrolled.

View Article and Find Full Text PDF